Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference
02 Décembre 2024 - 1:00PM
Business Wire
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a
biotechnology company devoted to discovering and developing
innovative therapies designed to treat immune-mediated and
metabolic diseases, today announced that Todd C. Brady, M.D.,
Ph.D., President and Chief Executive Officer, will participate in
the Eyes Wide Open on Ophthalmology Panel at the Citi 2024 Global
Healthcare Conference. The conference is being conducted in Miami,
Florida December 2-5, 2024.
Dr. Brady’s participation in the Eyes Wide Open on Ophthalmology
Panel is scheduled to begin at 1:45 p.m. ET on Thursday, December
5, 2024. To view the live webcast, log in to the Investors &
Media section of the Aldeyra website at https://ir.aldeyra.com.
Following the fireside chat, the webcast will be archived for 90
days.
About Aldeyra Aldeyra Therapeutics is a biotechnology
company devoted to discovering innovative therapies designed to
treat immune-mediated and metabolic diseases. Our approach is to
develop pharmaceuticals that modulate protein systems, instead of
directly inhibiting or activating single protein targets, with the
goal of optimizing multiple pathways at once while minimizing
toxicity. Our product candidates include RASP (reactive aldehyde
species) modulators ADX-629, ADX-248, ADX-743, ADX-631, and
chemically related molecules for the potential treatment of
systemic and retinal immune-mediated and metabolic diseases. Our
late-stage product candidates are reproxalap, a RASP modulator for
the potential treatment of dry eye disease and allergic
conjunctivitis, and ADX-2191, a novel formulation of intravitreal
methotrexate for the potential treatment of retinitis
pigmentosa.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241202913411/en/
Investor & Media Contact: Laura Nichols Tel: (781)
257-3060 investorrelations@aldeyra.com
Aldeyra Therapeutics (NASDAQ:ALDX)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
